FNY Investment Advisers’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1000 |
|
|
2020
Q4 | – | Sell |
-750
| Closed | -$113K | – | 887 |
|
|
2020
Q3 | $113K | Buy |
+750
| New | +$113K | 0.05% | 209 |
|
|
2020
Q2 | – | Sell |
-564
| Closed | -$80K | – | 597 |
|
|
2020
Q1 | $80K | Buy |
564
+531
| +1,609% | +$75.3K | 0.06% | 195 |
|
|
2019
Q4 | $4K | Sell |
33
-832
| -96% | -$101K | ﹤0.01% | 663 |
|
|
2019
Q3 | $86K | Sell |
865
-661
| -43% | -$65.7K | 0.03% | 328 |
|
|
2019
Q2 | $104K | Buy |
+1,526
| New | +$104K | 0.03% | 243 |
|